List of Angion Biomedica Corp. patents

Patents where

Current Assignee

Name

Angion Biomedica Corp.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10414760 Cytochrome P450 inhibitors and uses thereof	Patent 10414760 was granted and assigned to Angion Biomedica Corp. on September, 2019 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10414760	September 17, 2019
‌ US Patent 11542256 Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors	Patent 11542256 was granted and assigned to Angion Biomedica Corp. on January, 2023 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	11542256	January 3, 2023
‌ US Patent 11370783 Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole		Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	11370783	June 28, 2022
‌ US Patent 9597321 Antifibrotic compounds and uses thereof	Patent 9597321 was granted and assigned to Angion Biomedica Corp. on March, 2017 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	9597321	March 21, 2017
‌ US Patent 10851095 Methods and agents for treating disease	Patent 10851095 was granted and assigned to Angion Biomedica Corp. on December, 2020 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10851095	December 1, 2020
‌ US Patent 10287282 Methods and agents for treating disease	Patent 10287282 was granted and assigned to Angion Biomedica Corp. on May, 2019 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10287282	May 14, 2019
‌ US Patent 9040555 Antifibrotic compounds and uses thereof	Patent 9040555 was granted and assigned to Angion Biomedica Corp. on May, 2015 by the United States Patent and Trademark Office.		Angion Biomedica Corp.	United States Patent and Trademark Office	9040555	May 26, 2015
‌ US Patent 11434234 Methods and agents for treating disease		Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	11434234	September 6, 2022
‌ US Patent 11459319 Cytochrome P450 inhibitors and uses thereof	Patent 11459319 was granted and assigned to Angion Biomedica Corp. on October, 2022 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	11459319	October 4, 2022
‌ US Patent 10556893 Cytochrome P450 inhibitors and uses thereof	Patent 10556893 was granted and assigned to Angion Biomedica Corp. on February, 2020 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10556893	February 11, 2020
‌ US Patent 9988374 Cytochrome P450 inhibitors and uses thereof	Patent 9988374 was granted and assigned to Angion Biomedica Corp. on June, 2018 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	9988374	June 5, 2018
‌ US Patent 10899750 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity	Patent 10899750 was granted and assigned to Angion Biomedica Corp. on January, 2021 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10899750	January 26, 2021
‌ US Patent 10875849 Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole		Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10875849	December 29, 2020
‌ US Patent 11504359 Antifibrotic compounds and uses thereof	Patent 11504359 was granted and assigned to Angion Biomedica Corp. on November, 2022 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	11504359	November 22, 2022
‌ US Patent 8865752 Cytochrome P450 inhibitors and uses thereof	Patent 8865752 was granted and assigned to Angion Biomedica Corp. on October, 2014 by the United States Patent and Trademark Office.		Angion Biomedica Corp.	United States Patent and Trademark Office	8865752	October 21, 2014
‌ US Patent 8513433 Small molecule inhibitors of PARP activity	Patent 8513433 was granted and assigned to Angion Biomedica Corp. on August, 2013 by the United States Patent and Trademark Office.		Angion Biomedica Corp.	United States Patent and Trademark Office	8513433	August 20, 2013
‌ US Patent 10195184 Antifibrotic compounds and uses thereof	Patent 10195184 was granted and assigned to Angion Biomedica Corp. on February, 2019 by the United States Patent and Trademark Office.	Angion Biomedica Corp.	Angion Biomedica Corp.	United States Patent and Trademark Office	10195184	February 5, 2019
‌ US Patent 7648978 Small molecule modulators of cytokine activity	Patent 7648978 was granted and assigned to Angion Biomedica Corp. on January, 2010 by the United States Patent and Trademark Office.		Angion Biomedica Corp.	United States Patent and Trademark Office	7648978	January 19, 2010
‌ US Patent 8193177 Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases	Patent 8193177 was granted and assigned to Angion Biomedica Corp. on June, 2012 by the United States Patent and Trademark Office.		Angion Biomedica Corp.	United States Patent and Trademark Office	8193177	June 5, 2012
‌ US Patent 8513291 Cytochrome P450 inhibitors and uses thereof	Patent 8513291 was granted and assigned to Angion Biomedica Corp. on August, 2013 by the United States Patent and Trademark Office.		Angion Biomedica Corp.	United States Patent and Trademark Office	8513291	August 20, 2013

20 results

0 selected

20 results

0 selected